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We describe in this report the presence of a nuclear localization signal (NLS) overlapping the cal-
modulin-binding domain (CaM-BD) of the growth factor receptor bound protein 7 (Grb7). We show
that deletion of the CaM-BD of Grb7 prevents its nuclear localization, and that its Src homology 2
(SH2) domain might participate as well in the translocation process. Also, treating cells with the
CaM antagonist N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) enhances the pres-
ence of Grb7 in the nucleus. We propose that CaM inhibits the translocation of Grb7 to the nucleus
after binding to its CaM-BD and therefore occluding its overlapping NLS.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The growth factor receptor bound protein 7 (Grb7) is an adaptor
that regulates multiple cellular functions by interacting with
different tyrosine kinase receptors and other phospho-tyrosine
proteins. It gives name to a family of proteins, which also includes
Grb10 and Grb14 [1–6]. The Grb7 family members share a similar
structural organization, composed by an amino-terminal PR region,
a central GM region (for Grb and Mig10) [6] that includes a
RA domain, a PH domain and a BPS domain (for between PH and
SH2). The SH2 domain, important because of its binding tochemical Societies. Published by E
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illalobo).phospho-tyrosine residues in target proteins, is located at its car-
boxyl-terminal [1,2,4,6].
We have previously described the presence of a CaM-BD located
at the proximal region of the PH domain forming a predicted
amphiphilic a-helix, and that a Grb7 mutant lacking the CaM-BD
loses the ability to bind CaM and membrane phosphoinositides
[7]; however the functional relevance of this CaM-BD is still
unknown.
A basic amino acidic sequence is a common feature shared by
different NLSs and classical amphiphilic a-helices that conform
the CaM-BDs of many proteins. Overlapping of both sequences fre-
quently occurs (see Table 1 and references therein). In other
instances, both regions do not overlap but are in close proximity,
as in the nuclear matrix protein denoted matrin 3 [8]. This close
association also suggests a regulatory role of CaM on the transloca-
tion process.
Nuclear Grb7 has been shown to aid in the coordinated exit of
a KOR speciﬁc mRNA–protein export complex from the nucleus
after the EGF-mediated dephosphorylation of Grb7 by SHP-2,
and the subsequent rephosphorylation of the adaptor protein
by FAK inducing the release of the mRNA to start translation
[12].
In this report we investigate the role of CaM regulating Grb7
translocation into the nucleus, as Grb7D (a deletion mutant lacking
the CaM-BD), is unable of nuclear localization. Moreover, cell treat-
ment with the CaM antagonist W-7 results in a massive transloca-
tion of Grb7 into the nucleus, suggesting that CaM is regulating this
process.lsevier B.V. All rights reserved.
Table 1
Overlapping of the CaM-BD and NLS.
Protein CaM-BD/NLS Reference
hGrb7 RKLWKRFFCFLRRS [7]
BASP1 GGKLSKKKK [32]
EGFR RRRHIVRKRTLRRLLQ [16,17]
hSOX1 KRPMNAFMVWSRGQRRK [18,20]
hSOX9 RRPMNAFMVWAQAARRK [18,20]
hSRY KRPMNAFIVWSRDQRRK [19]
Kir/Gem KRKESMPRKARR [22]
TAP-Tag KRRWKKNFIAVSAANRFKK [33]
The sequences corresponding to the CaM-BD and the overlapping NLS of different
proteins are indicated. Clusters of basic amino acid residues are highlighted in bold.
Fig. 1. Deletion of the CaM-BD in FLAG-Grb7 and EYFP-Grb7 prevents its presence
in the nucleus. (A) The non-nuclear fraction (NNF) and the nuclear fraction (NF)
from HEK293 cells transiently transfected with either pcDNA3.1, pcDNA3/FLAG-
Grb7, pcDNA3/FLAG-Grb7D, pEYFP, pEYFP-Grb7 or pEYFP-Grb7D were processed
for Western blots as described in Section 2 using the anti-Grb7 (N-20) and anti-YFP
antibodies. (B) Immunoprecipitation (IP) of FLAG-Grb7 and FLAG-Grb7D from NNF
and NF using anti-FLAGM2 afﬁnity gel. Anti-GAPDH and anti-lamin B or anti-PARP
antibodies were used as loading controls and to ascertain the absence of cross-
contamination between the NNF and NF.
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2.1. Reagents
ProLong Gold antifade reagent, FBS, DMEM, and DAPI were
obtained from Invitrogen, and W-7 from Calbiochem. The X-ray
ﬁlms (Curix RP2 Plus) were from Agfa Healthcare. The ExSite muta-
genesis kit was from Stratagene. The rabbit polyclonal anti-Grb7
(N-20 and C-20) and the goat polyclonal anti-lamin B (C-20)
antibodies were from Santa Cruz Biotechnology. Rabbit monoclo-
nal anti-GAPDH and anti-PARP antibodies were from Cell Signaling
Technology. HRP-conjugated goat anti-rabbit IgG (H+L) antibody
was from Zymed Laboratories. Fibronectin (from bovine plasma),
FLAG-M2 afﬁnity gel and anti-FLAG-M2 monoclonal mouse
antibody were purchased from Sigma. The HRP-conjugated donkey
anti-goat IgG antibody was from Promega Co. The anti-GFP
antibody, also recognizing the variant EYFP, was from Roche
Diagnostics.
2.2. Vectors preparation
The FLAG-tagged Grb7 and Grb7V open reading frames were
ampliﬁed by PCR using the vector pCR3/FLAG-Grb7 and pCR3/
FLAG-Grb7V as templates and the following oligonucleotides: for
Grb7 forward primer 50-GAT GAC GAT CAT ATG GAG CCG GAT CTG
TCTCCACCT CATC-30 containing aNdeI restriction site (underlined),
reverse primer 50-GCC AGT CCA CGC TCG AGT CAG AGG GCC ACC
CGC GTG CAG C-30 containing a XhoI restriction site (underlined);
for Grb7V the same forward primerwas used and the reverse primer
was 50-GCA GGA TGA GAT CTC GAG TCA CTT TCT GCA GGT GGC ACA
AAG-30 containing a XhoI restriction site (underlined) [7]. The CaM-
BD deletion (residues 243–256) mutants Grb7D and Grb7VD were
generated with the ExSite mutagenesis kit (Stratagene) using
pCR3/FLAG-Grb7 and pCR3/FLAG-Grb7V as templates and the fol-
lowing oligonucleotides: forward primer 50-TCC TGA ACC CCG
CAG CTG CAG AAA GCC CTG-30 and reverse primer 50 GGC GTC
TAT TAC TCC ACC AAG GGC ACC TCT AAG-30 [7]. The PCR products
were subcloned into pcDNA3 using the EcoRI and XhoI restriction
enzymes yielding the pcDNA3/FLAG-Grb7, pcDNA3/FLAG-Grb7D,
pcDNA3/FLAG-Grb7V and pcDNA3/FLAG-Grb7VD vectors. The pEY-
FP-Grb7 and pEYFP-Grb7D vectorswere prepared by subcloning the
inserts from pCR3-FLAG-Grb7 and pCR3-FLAG-Grb7D into pEYFP-
C1 using the restriction enzymes XhoI and KpnI after elimination
of the FLAG tag as previously described [7].
2.3. Cell culture and transfection
Authenticated human embryonic kidney HEK293 (ATCC num-
ber CRL-1573), and rat glioma C6 (ATCC number CCL-107) cells
were obtained from the American Type Culture Collection (Manas-
sas, VA). The cell lines were grown in DMEM supplemented with10% (v/v) FBS, 2 mM L-glutamine, 40 lg/ml gentamicin (plus
1 mg/ml G418 in the case of the stable transfectants) at 37 C in
a humiﬁed atmosphere containing 5% CO2. The HEK293 and C6
cells were, respectively, transfected with the calcium phosphate
method [7] or the jetPEI™ transfection kit as described by the
manufacturer using the following plasmids: pcDNA3.1, pcDNA3/
FLAG-Grb7, pcDNA3/FLAG-Grb7D, pEYFP, pEYFP-Grb7 or pEYFP-
Grb7D.2.4. Nuclear fractionation
The nuclear fractions were prepared as described [9]. Brieﬂy: HE
K293 cells transiently transfected with pcDNA3.1, pcDNA3/FLAG-
Grb7, pcDNA3/FLAG-Grb7D, pEYFP, pEYFP-Grb7 or pEYFP-Grb7D
vectors were collected in a hypotonic lysis buffer containing 20
mM Hepes-NaOH (pH 7.0), 10 mM KCl, 2 mM MgCl2, 0.5% (v/v)
Nonidet P-40, 1 mM Na3VO4 and a protease inhibitors cocktail,
and homogenized on ice by 30 strokes using a Dounce homoge-
nizer. After centrifugation at 1500gmax for 5 min, the supernatant
(non-nuclear fraction) was collected, and the pellet containing
the nuclei was washed four times with the same buffer. The nuclei
were resuspended in the same buffer supplemented with 0.5 M
NaCl to extract the nuclear proteins. The samples were centrifuged
at 15000gmax for 10 min and the supernatant (nuclear fraction)
was collected. The protein concentration was determined using
the BCA™ protein assay kit.
Fig. 2. The truncated variant Grb7V is present in the nucleus in lesser amount than wild type Grb7. (A) Western blot analysis of the NNF and the NF from HEK293 cells
transiently transfected with pcDNA3.1, pcDNA3/FLAG-Grb7, pcDNA3/FLAG-Grb7D, pcDNA3/FLAG-Grb7V or pcDNA3/FLAG-Grb7VD. Anti-GAPDH and anti-lamin B antibodies
were used as loading controls and to ascertain the absence of cross-contamination between the NNF and NF. (B) The plot presents the NF/NNF ratio of the mean ± S.E.M.
(n = 3) densitometric signal of Grb7. ⁄⁄⁄p < 0.001.
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Proteins from both nuclear and non-nuclear fractions were
immunoprecipitated at 4 C overnight with anti-FLAG-M2 Afﬁnity
Gel. The next day, beads were washed four times and the immuno-
complexes eluted with loading buffer (60 mM Tris–HCl pH 6.8, 5%
(v/v) glycerol, 1.5% (w/v) SDS, 100 mM dithiothreitol and 0.05% (w/
v) bromophenol-blue).
2.6. W-7 treatment and ﬁbronectin seeding
Forty-eight hours post-transfection, trypsin-detached serum-
starved HEK293 cells were resuspended in DMEM, treated with
15 lMW-7 for 30 min and reseeded on 10 lg/ml ﬁbronectin-
coated plastic plates or glass cover slips. The cells were collected
30–60 min later for nuclear fractionation or for confocal micros-
copy. Long-term treatment was performed by adding daily
30 lM W-7 to the cells.
2.7. Confocal microscopy
Cells transfected with pEYFP-Grb7 or pEYFP-Grb7D were
washed twice with PBS and ﬁxed with 4% (v/v) paraformaldehyde
for 20 min and then permeabilized with 0.5% (v/v) Triton X-100
for 10 min. The cells were washed again with PBS and stained with
DAPI (1:500 dilution) for 10 min. The ProLong Gold Antifade Re-
agent was used as mounting solution. Cells were visualized using
a Leica TCS SP5 confocal ﬂuorescence microscope with a 63 (HCSPL APO lambda blue) oil-immersion objective using the UV and
488 nm lasers.
2.8. Statistical analysis
The Student’s t test was performed using the GraphPad Prism
software program (GraphPad Software Inc.). Differences were con-
sidered signiﬁcant at p 6 0.05.
3. Results
3.1. The CaM-BD deletion mutant Grb7D fails to localize in the nucleus
We ﬁrst studied the localization on Grb7 inside the nucleus.
Subcellular fractionation showed that both FLAG-Grb7 and
EYFP-Grb7 were detectable in the NF as well as in the NNF of
transiently transfected cells. However, the CaM-BD deletion
mutant Grb7D failed to localize in the NF (Fig. 1A) suggesting that
the CaM-BD is essential for nuclear localization. These observa-
tions were supported by immunoprecipitation using anti-FLAG-
M2 afﬁnity gel from both the NNF and NF from HEK293 cells
stably expressing FLAG-Grb7 or FLAG-Grb7D (Fig. 1B). The upper
band of Grb7D in the stable transfectants most likely represents
some phosphorylation of the protein at its C-terminal, as only
the lower band was detected using an anti-Grb7 (C-20) antibody
recognizing its C-terminal end, and alkaline phosphatase treat-
ment signiﬁcantly affect the migration of the upper band (not
shown).
Fig. 3. The CaM antagonist W-7 enhances the translocation of EYFP-Grb7 into the nucleus. HEK293 cells transiently transfected with pEYFP-Grb7 and pEYFP-Grb7D were
incubated for 60 min (top panel) or 30 min (bottom panel) in the absence () and presence (+) of 15 lMW-7. Thereafter, the cells were seeded on ﬁbronectin-coated plates,
and 30 min later the cells were ﬁxed, stained with DAPI and observed in a confocal ﬂuorescence microscope as described in Section 2. Representative images of cells
expressing EYFP-Grb7 and EYFP-Grb7D are shown.
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localization
To determine whether the SH2 domain of Grb7 was required for
its nuclear translocation we compared the location of Grb7 and
Grb7V, a truncated variant that lacks the SH2 domain [10], at the
nuclear fraction. Fig. 2 shows that Grb7V was detectable in the
nuclear fraction but in lesser extent (40%) than Grb7. The
deletion of the CaM-BD in both Grb7 and Grb7D prevented this
localization. This suggests that the SH2 domain plays a relevant
role in the nuclear translocation process.
3.3. W-7 enhances Grb7 translocation into the nucleus
To study the role of CaM in the control of the nuclear transloca-
tion of Grb7, we used W-7 to inhibit CaM. Confocal ﬂuorescence
studies of HEK293 cells transiently transfected with pEYFP-Grb7
and pEYFP-Grb7D showed that inhibition of CaM by W-7 led to a
massive translocation of EYFP-Grb7 into the nucleus, while thisinhibitor had no effect on EYFP-Grb7D localization (Fig. 3). Similar
results were obtained in rat glioma C6 cells expressing both tran-
siently and stably transfected EYFP-Grb7 and EYFP-Grb7D (not
shown). These results were conﬁrmed by Western blot of the
NNF and NF of HEK239 cells transiently transfected with FLAG-
Grb7 (Fig. 4). To test for long-term effects of the CaM antagonist,
we treated HEK293 cells with W-7 for several days. Fig. 5 shows
the progressive increase of Grb7 in the NF at longer times of
exposure to W-7.
4. Discussion
Grb7 is an adaptor protein that plays important roles in trans-
mitting signals from the cell surface to the cell interior. This adap-
tor has recently been identiﬁed as an RNA-binding protein,
interacting through the PR domain with KOR mRNA [11]. Grb7
works as a constitutive translational repressor, when it binds
directly to the 50-UTR of the target mRNA, blocking the recognition
of the mRNA by the translational initiator complex. Grb7 when
Fig. 4. The CaM antagonist W-7 enhances the presence of Grb7 in the nucleus.
HEK293 cells transiently transfected with pcDNA3/FLAG-Grb7 (A) or pcDNA3/FLAG-
Grb7D (B) were treated with 15 lM W-7 for 30 min prior to subcellular fraction-
ation. A control of cells transfected with the empty vector (EV) pcDNA3.1 is also
shown. (A, B) Western blot analyses of the NNF and the NF using an anti-Grb7 (N-
20) antibody. Anti-GAPDH and anti-lamin B antibodies were used as loading
controls and to ascertain the absence of cross-contamination between the NNF and
NF. (C) The plot presents the densitometric NF/NNF ratio of Grb7 in the absence and
presence of W-7 corresponding to the experiment shown in panel A.
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nucleus to the cytoplasm in a EGF-dependent manner, forming a
nuclear export complex with other proteins such as HuR and
CRM1 [12]. However, no mechanism of nuclear import of Grb7
has been proposed yet. Large proteins harboring a NLS enter in
the nucleus by an energy-dependent process [13]. Several NLS con-
sensus sequences have been described. The classical NLS consensus
sequence consists of clusters of basic amino acids separated by
some unrelated amino acids [14,15]. We propose that the CaM-
BD of Grb7 comprising the sequence 243RKLWKRFFCFLRRS256 is a
classical basic NLS sequence.
As Table 1 shows many CaM-BDs in different proteins overlap
with their known NLSs. This occurs in the EGFR that binds CaM
and is also translocated into the nucleus [16,17]. Moreover, the
translocation of the transcription factors SRY and SOX into the
nucleus is mediated by two NLSs: one working through importin
a1 (a-NLS), and the other by binding calmodulin (CaM-NLS)
[18–20]. The CaM-NLS sequence of these proteins is highly con-
served [18,20]. Nuclear translocation of SRY occurs by a mutual
exclusive mechanism involving only one of the two NLSs, where
switching between both of them depends on the concentration ofintracellular calcium available at a given time [21]. Three NLSs
have been identiﬁed in the small G protein Kir/Gem one of which
has CaM binding capacity as well [22]. p21Cip1 translocation into
the nucleus is also controlled by CaM [23]. A peptide encoding ami-
no acids 145–164 of p21Cip1, binds CaM and also comprises part of
its previously described NLS [23]. The export of proteins out of the
nucleus can also be regulated by CaM, as for example GRK5 where
the Ca2+/CaM complex binds to the N-terminal CaM-BD to aid in
the export process [24].
The region responsible for the localization of the SV40 large-T
antigen in the nucleus was identiﬁed by deletion of a basic
sequence deﬁning its NLS [25,26]. Using a similar approach we
have demonstrated that deletion of a basic sequence of Grb7
corresponding to its CaM-BD also prevents its nuclear localization.
We have described that the truncated variant Grb7V lacking
the SH2 domain is able to localize in the nucleus but in lesser
extent than Grb7. This suggests that the SH2 domain of Grb7
plays an important role controlling its entry into the nucleus.
SH2 domains work as docking sites allowing the binding to phos-
pho-tyrosine residues of target proteins. We hypothesized that
the absence of this domain may impair the binding of a phos-
pho-protein(s) that could facilitate Grb7 nuclear import. In this
context, the nuclear entry of TSAd facilitated by a tyrosine-phos-
phorylated protein ligand interacting with the SH2 domain has
been described [27].
The SH2 structure of Grb7 in solution shows two external
a-helices and two central b-sheets exposing an overall net high neg-
ative electrostatic surface potential [28]. We speculated that the
SH2 and PH domains of Grb7 could suffer an intermolecular electro-
static interaction helping to expose the overlapping CaM-BD/NLS to
the nuclear translocating machinery. The absence of a crystallo-
graphic structure of the whole Grb7 molecule prevents us to elabo-
rate further on this hypothetical interaction. If conﬁrmed it could
explain why Grb7V is less efﬁciently translocated than Grb7.
The CaM antagonist calmidazolium prevents the nuclear trans-
location of SOX9 [18] and SRY [19,29] demonstrating that CaM
positively controls the translocation process. A similar effect is ob-
served in p21Cip1 translocation [23]. In contrast, CaM inhibits the
translocation of Kir/Gem [22] and the transcription factor c-Rel
[30] into the nucleus, similarly to what occurs with Grb7.
The crystallographic structure of the full-length Grb7 has not
been established yet. Therefore, it is not known the structure of
the identiﬁed CaM-BD in the proximal region of the PH domain,
although a helical conformation was proposed [7]. However, the
structure of the RA and PH domains of Grb10 shows that this seg-
ment is not helical but a b-strand within a b-sheet [31], suggesting
that this might be the same in Grb7 because of the high homology
sequence of this segment. We have found that the three Grb7/10/
14 proteins are indeed CaM-binding proteins (García-Palmero
and Villalobo, unpublished results). However, deletion of this
homologous segment has a differential effect on CaM binding,
being Grb7D the one with far lower capacity to bind CaM, as com-
pared to Grb10D and Grb14D (García-Palmero and Villalobo,
unpublished results).
In conclusion, we propose that binding of CaM to Grb7 occludes
its NLS, preventing the translocation of this adaptor protein into
the nucleus. Conversely, inhibition of CaM leads to a higher
exposition of the NLS resulting in increased nuclear localization.
Hence, CaM plays an important role controlling the nuclear
localization of Grb7.
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